Ciclosporin in Goodpasture's syndrome

Nephron. 1992;60(3):355-9. doi: 10.1159/000186778.

Abstract

We report the case of a 39-year-old male patient with Goodpasture's syndrome. Despite therapy with prednisone, cyclophosphamide and plasma exchanges, serum creatinine (Scr) progressively increased up to 10.3 mg/dl (936 mumol/l) and hemoptysis recurred 3 months after initiation of treatment. Ciclosporin (CS) starting at 6 mg/kg/day was given. Scr began to decrease 2 weeks later and eventually stabilized at approximately 2.0 mg% (182 mumol/l). This case illustrates one of the potential uses of CS in human glomerular disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Glomerular Basement Membrane Disease / drug therapy*
  • Anti-Glomerular Basement Membrane Disease / pathology
  • Cyclophosphamide / therapeutic use
  • Cyclosporine / therapeutic use*
  • Glomerular Mesangium / pathology
  • Humans
  • Kidney Glomerulus / pathology*
  • Male
  • Plasma Exchange
  • Prednisone / therapeutic use

Substances

  • Cyclosporine
  • Cyclophosphamide
  • Prednisone